RadNet says it intends to acquire Truxtun, Health Diagnostics

Article

Los Angeles-based firm RadNet announced on March 15 it entered into letters of intent to acquire Truxtun Radiology Medical Group and the New Jersey operating subsidiary of Health Diagnostics.

Los Angeles-based firm RadNet announced on March 15 it entered into letters of intent to acquire Truxtun Radiology Medical Group and the New Jersey operating subsidiary of Health Diagnostics. Health Diagnostics has four locations in New Jersey: Edison, Freehold, Green Brook, and Old Bridge.

In their quarterly report, RadNet says it expects the cash consideration for the acquisitions will be approximately $24.5 million, plus 375,000 shares of common stock.

On the day of the announcement RadNet’s stock price closed 19 cents higher at $3 per share.

The acquisitions are not the only ones this year. On Jan. 1 RadNet acquired Union Imaging Center in N.J.

“All three acquisitions are of high quality multi-modality operators, which will strengthen our presence and competitive position in existing core markets of RadNet,” Dr. Howard Berger, RadNet’s chairman and CEO, said in the earnings release.

RadNet, founded in 1980, has approximately 4000 employees and operates in seven states: California, Maryland, Delaware, New Jersey, New York, Florida, and Kansas. RadNet. It has a network of 175 owned and operated outpatient imaging centers.

Dr. Girish Patel, who founded Bakersfield, CA-based Truxtun Radiology Medical Group, will remain as medical director of Truxtun for five years.

“This offer gave him the opportunity to plan for his eventual exit without leaving the business he founded 27 years ago, and with the assurance the business will continue even after he retires,” said Chip Robinson, chief operating officer of Truxtun.

The sale is expected to close sometime in April.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.